In TME, ADO is produced by the activity of ecto-nucleosidetriphosphate-diphosphohydrolase (E-NTPDase1 or CD39) and ecto-5′-nucleotidase (CD73) expressed by hematopoietic (MSCs) and cancer cells that hydrolyze the extracellular ATP. Here, NT5E is linked to cancer.